期刊文献+

葛根素乙酰化衍生物的合成和生物利用度研究 被引量:3

Research on Synthesis and Bioavailability of Puerarin Acetyl Derivatives
下载PDF
导出
摘要 本文利用乙酸酐和葛根素反应制备葛根素全乙酰化产物,经碳酸氢钠溶液进行不完全水解,用硅胶层析法对水解产物进行分离,通过紫外、红外、核磁共振和质谱等方法对产物进行鉴定,测定其口服生物利用度。获得四乙酰、五乙酰和六乙酰葛根素,口服生物利用度分别为葛根素的2.24,1.67和1.15倍。结果表明葛根素乙酰化衍生物的口服生物利用度高于葛根素,其中四乙酰葛根素口服生物利用度最高。 To probe into the method of improving oral bioavailability of Puerarin. Prepare the Puerarin derivatives through the way of synthesizing Puerarin and acetic anhydride, and then hydrolyze with liquor of sodium bicarbonate incompletely. Separate the hydrolysate by column chromatography. Confirm the structures of the derivatives by UV, IR, NMR and MS, and measure their bioavailability. The oral bioavailability of the three new resultant derivatives, as tetra-acetyl, pentaacetyl,and hexa-acetyl,is 2.24,1.67 and 1.15 times than Puerarin respectively. There are improvements in oral bioavailability of Puerarin acetylated derivatives, in which tetra-acetyl is the best.
出处 《天然产物研究与开发》 CAS CSCD 2010年第B08期73-76,共4页 Natural Product Research and Development
关键词 葛根素衍生物 乙酰化 生物利用度 puerarin derivatives aeetylation bioavailability
  • 相关文献

参考文献5

  • 1ZhuXY(朱秀嫒),SuCY(苏成业),LiZH(李振华),etal.The metabolic fate of the effective components of puerariae(葛根)Ⅲ the metabolism of puerarin[J].药学学报,1979,.
  • 2SuCY(苏成业),ZhuXY(朱秀媛),LiZH(李振华),etal.The metabolic fate of the effective components of puerariae(葛根)Ⅱ Uptake distribution and excretion of14C daidzein in rat[J].药学学报,1978,.
  • 3李颖,潘卫三,陈士林,杨大坚,陈新滋,徐宏喜.葛根素磷脂复合物的制备及其固体分散体研究[J].中国药学杂志,2006,41(15):1162-1167. 被引量:41
  • 4Li Y(李颖),Yang DJ(杨大坚),Chen SL(陈士林),et al.Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm Res ,2008,25:563-577.
  • 5Li Y(李颖),Chen SL(陈士林),Yang DJ(杨大坚),et al.Pharmcokinetic,tissue distribution and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Development and Industrial Pharm ,2006 ,32 :413-422.

二级参考文献8

  • 1GABETTA E,BOMBAROELLI E,PIFFERL G.Complexes of flavanolignanes with phospholipids,preparation there of and associated pharmaceutical composition.Patent No,0209038[P].1987-01-21.
  • 2WUJM CHENDW ZHANGRH etal.The review of the pharmaceutical study on the natural active component—phospholipid complex[J].中国药学杂志,1998,33(1):9-11.
  • 3CHEN D C.Handbook of Chemical Standard Sample of Tradational Chinese Drug(中药化学对照品工作手册)[M].Beijing:ChinaMedico-Pharmaceutical Science and Technology Publishing House,2000.
  • 4BOMBARDELLI E,BIANCHETTI G.Pharmaceutical and cosmetic compositions containing complexes of flavanoligans with phospholipid.Patent No,0300282[P].1989-01-25.
  • 5BOMBARDELLI E,SPELTA M.Aging skin:protective effect of silymarin-phytosome[J].Fitoterapia,1991,62(2):115-119.
  • 6BI D Z.Pharmaceutics(药剂学)[M].Beijing:People's Medical Publishing House,1997.
  • 7施邑屏,黎燕斌,孙玲玲,冯青,李祖义.^(31)P核磁共振光谱及薄层色谱分析针剂大豆卵磷脂[J].分析化学,1991,19(7):733-736. 被引量:26
  • 8吴建梅,陈大为,刘艳丽.黄芩苷磷脂复合物制备工艺的研究[J].中国中药杂志,2001,26(3):166-169. 被引量:38

共引文献40

同被引文献21

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部